Introducing On Deck Longevity Biotech’s first job fair on February 3rd at 10AM PST! If you are searching for a role at the forefront of the longevity biotech field, this is the place for you. Here you will get the chance to discover roles from companies like Retro Biosciences, BioAge, Spring Discovery, Rubedo Life Science, Deciduous Therapeutics, Repair Biotechnologies, Cognito Therapeutics, Arrive Bio, Juvena Therapeutics, Underdog Pharma, Gameto, Arda Therapeutics, and more.
You can connect with their team members to more deeply learn about their cutting-edge work and network with fellow ambitious longevity biotech builders as well.
Check out more about ODLB here: https://beondeck.com/longevity-biotech
RSVP here: https://lu.ma/odlb-job-fair
Feel free to share this event with all who may be interested 😊
This section will continuously be updated until the date of the job fair.
The mission of Retro Biosciences is to extend healthy human lifespan by one decade.
Retro is an untraditional, well-funded, stealth bio startup headquartered in Redwood City. They are building interconnected programs centered on partial epigenetic reprogramming, blood plasma-inspired therapeutics, and autophagy. Retro’s early team includes brilliant early-career scientists and renowned names in the reprogramming field. They’re continuing to build a team of incredibly accomplished and kind individuals who embrace their startup culture of rapid iteration, transparency, and versatility.
Retro is looking to recruit exceptional people across multiple programs:
If you have relevant experience and a strong drive to advance longevity biotech, please apply to one of Retro’s open positions. Don’t see a relevant open position but excited by the mission? Send your resume and a brief description of how you would contribute to Retro to [email protected].
BioAge is a clinical-stage biotechnology company developing a pipeline of treatments to extend healthy lifespan by targeting the molecular causes of aging. They use their discovery platform, which combines quantitative analysis of proprietary longitudinal human samples with detailed health records tracking individuals over the lifespan, to map out the key molecular pathways that impact healthy human aging, thus revealing the causes of age-related disease. By targeting the mechanisms of aging with a large and mechanistically diverse portfolio of drugs, BioAge will unlock opportunities to treat or even prevent these diseases in entirely new ways. To date, they have raised $127M from Andreessen Horowitz, Kaiser Foundation Hospitals, and others. They currently have three clinical-stage programs in their growing portfolio.
Check out open positions here.
Spring builds world-leading technology that gives scientists the superpowers they need to develop therapies for aging. Treating the drivers of age-related disease is one of our most important chances to dramatically reduce suffering— and scientists on the front line of this battle are equipped with yesterday’s tools. We believe they should possess the best technology in the world.
They are hiring for multiple positions including:
Check out open positions here.